CW October 2005
Volume 14Issue Number 10 October 2005 ISSN 10593802 Vaccine Prevents Cervical Cancer DevelopmentAn investigational vaccine, Gradasil™, developed by Merck & Co., Inc., prevented 100% of high-grade cervical pre-cancers and non-invasive cervical cancers (CIN 2/3 and AIS) associated with humanpapillomavirus (HPV) types 16 and 18.
Go to Previous Page Go to Next Page Source & Additional Reading L. Koutsky et al., Annual Meeting of the Infectious Disease Society of America (IDSA). Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
